[1]
Ninu, J.J.A.S. and Faot, N.E. 2026. Effectiveness of the 6-month BPaLM regimen in a patient with rifampicin-monoresistant tuberculosis. Public Health Risk Assesment Journal. 3, 2 (Jan. 2026), 124–141. DOI:https://doi.org/10.61511/phraj.v3i2.2026.2224.